Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|December 1, 2004
- Volume 0 0
Workload Leads to Less Sleep
Advertisement
The American Time-Use Survey released by the Bureau of Labor Statistics revealed that more work leads to less sleep. The purposeof the survey was to estimate how Americans spend their time. The findings showed that nonworking individuals sleep morethan those who are employed (9.1 hours/night vs 8.3 hours/night). Additionally, the data indicated that individuals with multiple jobssleep less, compared with individuals holding a single job (7.9 hours/night vs. 8.3 hours/night).
Articles in this issue
almost 22 years ago
Treatment of Patients with Atrial Fibrillationalmost 22 years ago
Understanding and Managing Polypharmacy in the Elderlyalmost 22 years ago
Counterfeit Drugs: A Real Cause for Alarmalmost 22 years ago
New Treatments on the Way for Diabetes-Part 1almost 22 years ago
Effective Counseling for Patients with Hypertensionalmost 22 years ago
Preventing and Managing Thrombosis with Anticoagulantsalmost 22 years ago
RxPRODUCT NEWS: PROFILE: Cardizem LA (diltiazem hydrochloride)almost 22 years ago
Staying Well with Herbs and Vitaminsalmost 22 years ago
Health Professional Imposters-Part 1Advertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
2
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
3
Ramantamig's 93.6% ORR and Outpatient CRS Control
4
After 180 Years, Multiple Myeloma Gets a Definition of Cure
5